Multiple Sclerosis Drugs Market to Grow from USD 21.70 Billion in 2025 to USD 52.82 Billion by 2035, at a CAGR of 9.31%

SNS Insider estimates the Multiple Sclerosis drugs market at $21.70B in 2025, projected to grow to $52.82B by 2035, implying a ~9% CAGR. This is supportive for healthcare/biotech demand outlook, but the note does not include company-specific earnings, guidance, or pricing impacts.